Elevance Health, Inc. with price, financials, news flow, and insider context in one page.
Elevance Health, Inc. is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where ELV sits inside Healthcare and Healthcare Plans, and the key financial markers that matter before moving into a fuller research workflow.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
This page is structured for research context, not a trade call. It gives you a clean read on where ELV sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 50.18B | 1.76B | 4.1B |
| Q4 2025 | 49.75B | 547M | -209M |
| Q3 2025 | 50.71B | 1.19B | 775M |
| Q2 2025 | 49.78B | 1.74B | 1.79B |
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
Elevance Health, Inc. (ELV) — questions investors ask
What is the current stock price of Elevance Health, Inc. (ELV)?
Elevance Health, Inc. (ELV) is trading at $395.18, up 2.03% in the latest session. The live price and one-year chart on this page update through the trading day.
What is Elevance Health, Inc.'s market capitalization?
Elevance Health, Inc. has a market capitalization of about 85.82B, derived from the latest share price and shares outstanding.
When is Elevance Health, Inc.'s next earnings date?
Elevance Health, Inc. is next expected to report earnings on Jul 16, 2026. The ELV earnings page tracks the estimate and reporting history.
What is Elevance Health, Inc.'s P/E ratio?
Elevance Health, Inc. trades at a forward price-to-earnings ratio of 13.51 — one measure of how the market is pricing its future earnings.
What is ELV's 52-week trading range?
Over the past 52 weeks, ELV has traded between $273.71 and $426.98.
What sector is Elevance Health, Inc. in?
Elevance Health, Inc. operates in the Healthcare sector, within the Healthcare Plans industry.
Does Elevance Health, Inc. pay a dividend?
Elevance Health, Inc. currently carries a dividend yield of about 100.0%.
What is the analyst price target for ELV?
The mean analyst price target for ELV is $418.67, with an overall analyst view of Buy.
A public stock page should answer the first research questions before asking for a signup.
This ELV page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.